Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

XBIO

Xenetic Biosciences Inc

May 22 • 04:00PM ET

3.03

+0.09 3.03 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: TNXP SABS ARTL PALI BCDA

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.23	Insider Own	14.61%	Shs Outstand	2.29M	Perf Week	-0.49%
Market Cap	6.94M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	1.96M	Perf Month	-3.23%
Enterprise Value	-0.41M	PEG	-	EPS next Q	-	Inst Own	7.38%	Short Float	0.37%	Perf Quarter	34.03%
Income	-2.23M	P/S	2.18	EPS this Y	-	Inst Trans	-7.50%	Short Ratio	0.39	Perf Half Y	19.25%
Sales	3.19M	P/B	1.00	EPS next Y	-	ROA	-32.61%	Short Interest	0.01M	Perf YTD	39.59%
Book/sh	3.03	P/C	0.94	EPS next 5Y	-	ROE	-37.01%	52W High	13.93 -78.26%	Perf Year	-0.55%
Cash/sh	3.21	P/FCF	-	EPS past 3/5Y	30.07% 37.89%	ROIC	-32.14%	52W Low	1.90 59.42%	Perf 3Y	7.03%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	20.36% 46.78%	Gross Margin	-	Volatility	5.95% 5.29%	Perf 5Y	-84.14%
Dividend TTM	-	EV/Sales	-0.13	EPS Y/Y TTM	48.34%	Oper. Margin	-75.05%	ATR (14)	0.19	Perf 10Y	-99.67%
Dividend Ex-Date	-	Quick Ratio	7.93	Sales Y/Y TTM	23.52%	Profit Margin	-70.03%	RSI (14)	49.94	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	7.93	EPS Q/Q	65.98%	SMA20	-0.20%	Beta	2.20	Target Price	40.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	36.01%	SMA50	-1.36%	Rel Volume	1.05	Prev Close	2.94
Employees	2	LT Debt/Eq	0.00	Earnings	May 13 BMO	SMA200	3.62%	Avg Volume	18.69K	Price	3.03
IPO	Jun 19, 2012	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	19,695	Change	3.03%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)